C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 498/12 (2006.01) A61K 31/485 (2006.01) A61P 25/36 (2006.01)
Patent
CA 2647417
Ester derivatives of the phenolic hydroxyl group of buprenorphine are described that can be used in the treatment of opiate dependency and/or moderate to severe pain. The esters have an enhanced bioavailability, an enhanced duration of action, and a reduced abuse potential.
L'invention concerne des dérivés ester du groupe hydroxyle phénolique de la buprénorphine pouvant être utilisés dans le traitement de la dépendance aux opiacés et/ou de la douleur moyenne à aiguë. Les esters ont une biodisponibilité accrue, une durée d'action accrue et un potentiel d'abus réduit.
Chapleo Christopher Bourne
Lewis John William
Fetherstonhaugh & Co.
Reckitt Benckiser Healthcare (uk) Limited
LandOfFree
Buprenorphine derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Buprenorphine derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Buprenorphine derivatives and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1537011